glp-1 news today october 2025 Understanding GLP-1s and their dynamic marketplace and workplace trends GLP-1s for Weight Loss: What

In particular, incretin-based therapies and sodium-glucose co-transporter 2 (SGLT2) inhibitors have attracted increasing interest not only for their glucose-lowering effects, but also for their broader metabolic, renal, and cardiovascular benefits

Constipation is a common but often overlooked side effect in people taking GLP-1 receptor agonists, a class of medications widely used to treat obesity and type 2 diabetes

Here's who is (and is not) an ideal candidate for medical weight loss:

When people stopped taking one of the new weight-loss jabs they regained around 60% of their lost weight.

GLP-1 Receptor Agonists: A Comprehensive Look at Ozempic and Mounjaro for PCOS==========================================================================GLP-1 receptor agonists like Ozempic (semaglutide) and Mounjaro (tirzepatide) are generating significant buzz